Psoriasis treatment is organized by severity — mild, moderate, and severe — and within each level there are several distinct approaches. No single treatment works for every patient, and most people try more than one before finding what works consistently for them.

The right starting point depends on what percentage of body surface area is affected, where the psoriasis appears (scalp and nails often need different approaches than skin), and whether there's any joint involvement. A dermatologist determines severity and recommends accordingly.¹

Not necessarily — it depends on severity. Several effective psoriasis treatments are available over the counter without a prescription:

• Coal tar — Available in shampoos, creams, and ointments. One of the oldest and most validated OTC psoriasis treatments, explicitly recognized by the AAD. Works by slowing abnormal skin cell turnover and reducing inflammation.
• Salicylic acid — Available in shampoos and topical products. Works as a keratolytic — it softens and helps remove the thick scale that builds up on plaques, allowing other treatments to penetrate more effectively.
• Moisturizers and emollients — Not treatments in themselves, but an important part of daily management that reduces dryness, cracking, and itch regardless of what else you're using.

Topical corticosteroids, vitamin D analogues, retinoids, phototherapy, systemic medications, and biologics all require a prescription and varying levels of specialist involvement. If OTC treatments aren't producing clear improvement within 4–6 weeks, that's a reasonable point to see a dermatologist for a formal diagnosis and prescription options.¹

This varies considerably by treatment type. Here are realistic timeframes based on clinical data:

• Topical corticosteroids — Visible reduction in inflammation and itch within 1–2 weeks for mild cases. Plaques may clear partially or fully within 4–8 weeks of consistent use.
• Coal tar and salicylic acid — Slower acting than steroids. Expect gradual improvement over 4–8 weeks of nightly consistent use. These treatments work cumulatively — results build with sustained application.
• Phototherapy — Typically 2–3 sessions per week for 6–8 weeks before significant clearing. Some patients need maintenance sessions thereafter.
• Biologics — Most patients see meaningful improvement within 12–16 weeks. Some biologics show response as early as 4 weeks.
• Methotrexate — Generally takes 4–8 weeks for initial response; full effect at 3–6 months.

The most common reason treatments fail is inconsistent use — stopping when the skin looks better, then restarting when it flares. Psoriasis is a chronic condition and most effective treatments require consistent long-term application to maintain results.²

Treatment resistance is common in psoriasis, and it happens for several different reasons:

• Tachyphylaxis — The skin adapts to topical corticosteroids over time, reducing their effectiveness. The standard approach is to rotate treatments or take breaks from steroid use periodically.
• Biologic neutralization — The immune system can develop antibodies against biologic medications, reducing their effect. When this happens, switching to a different biologic targeting a different pathway often restores response.
• Trigger accumulation — Sometimes a treatment that was working stops because a new trigger has been added — increased stress, alcohol, a new medication, a change in diet. The treatment hasn't failed; the trigger load has increased.
• Disease progression — In some cases psoriasis genuinely becomes more severe over time and the current treatment tier is no longer adequate. This typically calls for stepping up to the next treatment category.

If a treatment that was working stops producing results, the first step is to talk to your dermatologist rather than simply increasing the dose. Identifying why it stopped working changes the response.¹

Topical corticosteroids are effective for controlling psoriasis flares, but they carry well-documented risks with extended continuous use:

• Skin thinning (atrophy) — Particularly on the face, skin folds, and any area used continuously for more than a few weeks.
• Skin discoloration and stretch marks — More common with higher-potency formulations.
• Rebound flares — Stopping steroid treatment abruptly can trigger a flare worse than the original. The skin becomes temporarily dependent on the anti-inflammatory signal.
• Systemic absorption — With high-potency steroids on large body surface areas over long periods, systemic absorption can affect adrenal function — particularly relevant in children.

The AAD recommends using topical steroids for flares and rotating to non-steroidal treatments — coal tar, vitamin D analogues, or moisturizers — for maintenance. This approach reduces the risk of tachyphylaxis and long-term side effects while keeping the steroid available as an effective acute option.¹

Not currently. Psoriasis is a chronic autoimmune condition driven by a genetic predisposition that causes the immune system to attack healthy skin cells. There is no treatment that corrects this underlying mechanism permanently — no drug, supplement, diet, or procedure.

What is achievable is remission — periods where symptoms are absent or minimal. Many patients with mild to moderate psoriasis achieve long periods of remission with consistent treatment and trigger management. Some biologic medications produce skin clearance that lasts months after stopping the drug. But remission is not cure — the condition can return, particularly if triggers are present or treatment is stopped.

The practical goal of psoriasis management is to minimize the frequency and severity of flares, keep the condition from affecting quality of life, and — if possible — achieve and sustain remission. For a meaningful number of patients this is fully achievable.³

For sustained daily use without the risks associated with corticosteroids, two OTC ingredients have the best combination of evidence and safety profile:

• Coal tar — Used in dermatology for over a century with no long-term toxicity concerns at OTC concentrations (up to 5%). It does not cause skin thinning, does not suppress the immune system, and has no systemic risk at standard use levels. It works by normalizing skin cell production rather than suppressing inflammation pharmacologically, which makes it suitable for long-term maintenance.
• Salicylic acid — Keratolytic action with no known tolerance development. Used long-term to manage scale buildup. Avoid use on large body surface areas at high concentrations for extended periods due to potential systemic absorption (relevant mainly for body-wide application).

Moisturizers and emollients are universally safe for daily, unlimited use and are an important part of any long-term psoriasis routine regardless of what else is being used. They don't treat psoriasis but they reduce the symptomatic burden significantly — less cracking, less itch, better skin barrier function.²

Not every case of psoriasis requires specialist care — mild cases are often manageable with OTC treatments. But there are specific situations where a dermatologist visit is important:

• You've been using OTC treatments for 4–6 weeks without meaningful improvement. This may mean the diagnosis is wrong, the severity is higher than mild, or a prescription option is needed.
• You have joint pain, stiffness, or swelling alongside your skin symptoms. Psoriatic arthritis requires early treatment to prevent joint damage — it shouldn't wait.
• Your psoriasis covers a large percentage of your body (generally 10% or more of body surface area — roughly the equivalent of both arms). This typically falls outside the range of OTC treatment.
• The condition is significantly affecting your quality of life — sleep, work, relationships, mental health. The psychological burden of psoriasis is clinically significant and under-treated.
• You're pregnant or planning to become pregnant. Many psoriasis treatments are contraindicated in pregnancy and a safe management plan needs to be established in advance.
• Your current treatment has stopped working. Resistance and disease progression require evaluation — not just increasing dose.

Yes — not directly in the sense that food interacts with treatment mechanisms, but indirectly through the inflammatory baseline it maintains. Psoriasis is an inflammatory disease, and the effectiveness of treatment partly depends on the starting level of inflammation you bring to it. A consistently pro-inflammatory diet — high in processed foods, refined sugars, alcohol, and red meat — maintains a higher systemic inflammatory state that works against treatment.

Specifically: alcohol consumption is documented to reduce the effectiveness of biologics and creates serious risks in combination with methotrexate. Obesity is associated with reduced biologic response — adipose tissue produces inflammatory cytokines that compete with the drug's mechanism. The AAD explicitly recommends weight reduction in overweight patients with psoriasis as part of treatment optimization.²

Cost varies enormously across the treatment spectrum. Here are realistic ranges:

• OTC treatments (coal tar, salicylic acid, moisturizers) — Typically $15–$60/month depending on the product and frequency of use. No insurance required.
• Prescription topical treatments — Generic corticosteroids and vitamin D analogues: $20–$80/month with insurance. Brand-name formulations without insurance can reach $200–$500/month.
• Phototherapy — $50–$150 per session without insurance. Most insurance plans cover phototherapy with a dermatologist's prescription, reducing out-of-pocket cost significantly. Home UVB units cost $500–$3,000 upfront but reduce the per-session cost substantially over time.
• Oral systemic medications — Methotrexate is inexpensive in generic form: $20–$50/month. Cyclosporine and acitretin are higher. Regular bloodwork adds to ongoing costs.
• Biologics — Without insurance, $15,000–$60,000 per year depending on the drug. With insurance and manufacturer copay assistance programs, many patients pay $0–$50/month. Manufacturer patient assistance programs exist for those who don't qualify for insurance coverage.

The cost gap between OTC treatments and prescription biologics is enormous. For mild to moderate psoriasis, starting with OTC coal tar and salicylic acid is both clinically appropriate and dramatically more accessible. These are not "lesser" treatments — they are the AAD's recommended first-line approach for mild disease.¹